One of the major goals of VTLCRC is to develop translational research that will have as one of its major requirements, patient specimens with clinical follow up. Animal experiments require careful histopathological Interpretation, sometimes with special histochemical and immunohistochemical techniques. The tumor bank core facility was set up to support such research activities and will play a crucial role in the future development of VTLCRC. The goals of the tumor bank core facility are: (1) to maintain a comprehensive bank of frozen and fixed tumor tissues with relevant clinical and laboratory information for use by VTLCRC investigators, 2) to provide a number of histopathology related services, and 3) to provide VTLCRC investigators expert help in conducting experiments utilizing specimens from human and animal subjects. The fresh frozen tumor banks has been in operation since February, 1991 in the pathology department. In addition the lymphoma tumor bank and prostate tumor bank have been in operation by other VTLCRC programs. To unify these three banks, increase the tumor accrual, and expand the range of provided services, the VTLCRC tumor bank core was established under the direction of Dr. Soonmyoung Paik, a board certified anatomic pathologist. IRB approval for obtaining patient follow up was obtained on Feb 20, 1992. A pathology assistant working full time in the surgical pathology grossing room is one of the unique features of this core. Since she is available 100% of the time to save tissue specimens, tissue accrual process is highly optimized. A comprehensive database is maintained for the banked specimens. The facility described in this proposal has thus far been supported only by a combination of CCSG Developmental Funds and the Cancer Center's discretionary funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-07
Application #
5207621
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1996
Total Cost
Indirect Cost
Pannkuk, Evan L; Laiakis, Evagelia C; Garcia, Melissa et al. (2018) Nonhuman Primates with Acute Radiation Syndrome: Results from a Global Serum Metabolomics Study after 7.2 Gy Total-Body Irradiation. Radiat Res :
Ahn, Jaeil; Conkright, Brian; Boca, Simina M et al. (2018) POPSTR: Inference of Admixed Population Structure Based on Single-Nucleotide Polymorphisms and Copy Number Variations. J Comput Biol 25:417-429
Ujjani, Chaitra; Wang, Hongkun; Skarbnik, Alan et al. (2018) A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. Blood Adv 2:762-768
Chang, Joanne T; Levy, David T; Meza, Rafael (2018) Examining the Transitions Between Cigarette and Smokeless Tobacco Product Use in the United States Using the 2002-2003 and 2010-2011 Longitudinal Cohorts. Nicotine Tob Res 20:1412-1416
Naab, Tammey J; Gautam, Anita; Ricks-Santi, Luisel et al. (2018) MYC amplification in subtypes of breast cancers in African American women. BMC Cancer 18:274
Alamri, Ahmad M; Liu, Xuefeng; Blancato, Jan K et al. (2018) Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Dis Model Mech 11:
Nomura, Sarah J O; Hwang, Yi-Ting; Gomez, Scarlett Lin et al. (2018) Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors. Breast Cancer Res Treat 168:467-479
Hinzman, Charles P; Baulch, Janet E; Mehta, Khyati Y et al. (2018) Exposure to Ionizing Radiation Causes Endoplasmic Reticulum Stress in the Mouse Hippocampus. Radiat Res 190:483-493
Tassi, Elena; Lai, En Yin; Li, Lingli et al. (2018) Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension 71:160-167
Burks, Julian; Nadella, Sandeep; Mahmud, Abdullah et al. (2018) Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer. Cell Mol Gastroenterol Hepatol 6:17-32

Showing the most recent 10 out of 1120 publications